These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34122618)

  • 1. Clinical Characteristics and Early Interventional Responses in Patients with Severe COVID-19 Pneumonia.
    He S; Fang L; Xia L; Lin S; Ye J; Luo D
    Comput Math Methods Med; 2021; 2021():6676987. PubMed ID: 34122618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
    Wu C; Chen X; Cai Y; Xia J; Zhou X; Xu S; Huang H; Zhang L; Zhou X; Du C; Zhang Y; Song J; Wang S; Chao Y; Yang Z; Xu J; Zhou X; Chen D; Xiong W; Xu L; Zhou F; Jiang J; Bai C; Zheng J; Song Y
    JAMA Intern Med; 2020 Jul; 180(7):934-943. PubMed ID: 32167524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
    Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
    Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
    Wang D; Hu B; Hu C; Zhu F; Liu X; Zhang J; Wang B; Xiang H; Cheng Z; Xiong Y; Zhao Y; Li Y; Wang X; Peng Z
    JAMA; 2020 Mar; 323(11):1061-1069. PubMed ID: 32031570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
    Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
    Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.
    Lian J; Jin X; Hao S; Jia H; Cai H; Zhang X; Hu J; Zheng L; Wang X; Zhang S; Ye C; Jin C; Yu G; Gu J; Lu Y; Yu X; Xiang D; Li L; Liang T; Sheng J; Yang Y
    Influenza Other Respir Viruses; 2020 Sep; 14(5):564-574. PubMed ID: 32397011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.
    Xu X; Yu C; Qu J; Zhang L; Jiang S; Huang D; Chen B; Zhang Z; Guan W; Ling Z; Jiang R; Hu T; Ding Y; Lin L; Gan Q; Luo L; Tang X; Liu J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1275-1280. PubMed ID: 32107577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
    Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD
    Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory Support in Severely or Critically Ill ICU Patients With COVID-19 in Wuhan, China.
    Hu HT; Xu S; Wang J; Rao X
    Curr Med Sci; 2020 Aug; 40(4):636-641. PubMed ID: 32767265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
    Huang S; Shen C; Xia C; Huang X; Fu Y; Tian L
    Med Sci Monit; 2020 Dec; 26():e928755. PubMed ID: 33264276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Outcomes of Acute Kidney Injury in Patients Infected with COVID-19 in Xiangyang, China.
    Yuan H; Liu J; Gao Z; Hu F
    Blood Purif; 2021; 50(4-5):513-519. PubMed ID: 33316799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of 2019 novel coronavirus pneumonia in Zhejiang province, China.
    Chen L; Jin Q; Zhou Y; Yang J; Wang Z; Ge K; Yang J; Wang H
    Mol Med Rep; 2020 Sep; 22(3):2583-2587. PubMed ID: 32705222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020.
    Sun H; Guo P; Zhang L; Wang F
    Med Sci Monit; 2020 Nov; 26():e926941. PubMed ID: 33175722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.